Moreover, scientists have realized that MAT1A is underexpressed in cases with advanced NAFLD, obviously insisting on a leading role for SAM in the pathogenesis of NAFLD in humans41,42. This evidence concerns the gene MAT1A and metabolic dysfunction-associated steatotic liver disease.